To approve unaudited Financial Results for the Quarter ended 30th June 2026

Registered & Corporate Office: AMANTA HEALTHCARE LIMITED 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat, INDIA. Tel.: 079 – 67777600 Email: info@amanta.co.in Website: www.amanta.co.in CIN: L24139GJ1994PLC023944 Date: August 5, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. Scrip Code: 544502 Trading Symbol: AMANTA Dear Sir / Madam, Sub: Outcome under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) for the meeting of Board of Directors of the Company held today on August 05, 2026. With reference to the captioned subject, we would like to inform that the Board of Directors of Amanta Healthcare Limited at its meeting held today, i.e. on Wednesday, August 5, 2026 have inter-alia considered and approved: 1. The Financial Results of the Company for the quarter ended June 30, 2026. 2. Limited Review Report of the Auditors with unmodified opinion of the Company for the quarter ended June 30, 2026. 3. Considered and approved the Board’s Report of the company for the Financial Year ended on 31st March, 2026. 4. Approved the Notice convening the 31st Annual General Meeting (AGM) of the Company proposed to be held on Wednesday, September 16, 2026, at 12:00 P.M. IST through Video Conferencing (VC)/Other Audio Visual Means (OAVM), deemed to be held at the Registered Office of the Company. 5. Approved the appointment of Mr. Kashyap R. Mehta (Membership No. 1821), Partner of M/s. Kashyap R. Mehta and Partners, Practicing Company Secretaries, Ahmedabad, as the Scrutinizer for conducting the remote e-voting process and e-voting during the AGM in a fair and transparent manner. 6. Approved the dissolution of IPO Committee w.e.f. August 05, 2026. The IPO Committee was initially constituted on August 24, 2024 to oversee and make decisions related to the initial public offering, in compliance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018. The detailed disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed herewith. The Meeting Commenced at 04:30 P.M. and concluded at 05:35 P.M. You are requested to take the same on your records. Thanking you, Yours faithfully, FOR, AMANTA HEALTHCARE LIMITED NIKHITA DINODIA COMPANY SECRETARY & COMPLIANCE OFFICER Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720